Trade Bicycle Therapeutics PLC - BCYC CFD

Trading Conditions

• Type: CFD
• Spread: 0.07
• Long position overnight funding adjustment: -0.02149%
• Short position overnight funding adjustment: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 4.31
• Open: 4.26
• 1-Year Change: -52.88%
• Day's Range: 4.24 - 4.54

What is Bicycle Therapeutics PLC (BCYC)?

Bicycle Therapeutics PLC is a biotechnology company specializing in the development of novel therapeutics based on bicyclic peptides. These peptides are designed to combine the specificity and affinity of antibodies with the favorable properties of small molecules, such as improved tissue penetration and stability. The company's platform technology enables the creation of drug candidates targeting a range of diseases, including cancer and infectious diseases. Bicycle Therapeutics operates with a focus on advancing its pipeline through clinical development and strategic collaborations. Its research and development efforts emphasize innovative approaches to drug discovery, leveraging the unique characteristics of bicyclic peptides to address challenging biological targets. The company is headquartered in the United Kingdom and engages in partnerships with pharmaceutical companies to enhance its capabilities and expand its therapeutic reach. Its work contributes to the broader field of peptide-based therapeutics, aiming to offer new treatment options for patients with unmet medical needs.

Bicycle Therapeutics PLC Stock Price Today: Live Overview

The price today is shaped by active market participation, as Cullen/Frost Bankers Inc trades at $4.52. The intraday range extends from $4.21 to $4.56, accompanied by a daily change of +4.186%.

FAQ: Bicycle Therapeutics PLC (BCYC)

What is the current price of BCYC stock?

The current price of Bicycle Therapeutics PLC is $4.52.

Does BCYC pay dividends?

Bicycle Therapeutics PLC does not pay dividends.

Does BCYC have a formal corporate presence or regional headquarters in the UAE?

Bicycle Therapeutics PLC has no official regional office or subsidiary in the UAE and operates through partners.

What is BCYC best known for?

Bicycle Therapeutics PLC is most famous for its development of bicyclic peptide therapeutics.

What assets are typically shown together with BCYC?

Commonly shown alongside BCYC: Midwich Group PLC, Supermarket Income REIT plc, Helia Group Ltd